Skip to main content
. 2023 Sep 26;13:92. doi: 10.1186/s13613-023-01179-w

Table 3.

Outcomes according to the presence of diaphragm dysfunction at ECMO Day 1

All patients (n = 63) Diaphragm dysfunction (n = 39) No diaphragm dysfunction (n = 24) P value
Tracheostomy, n (%) 25 (43) 15 (41) 10 (48) 0.600
Number of VAP episodes 3 (2–4) 3 (2–5) 3 (2–4) 0.397
Total MV duration, days 50 (37–71) 50 (34–70) 49 (38–73) 0.845
In survivors (n = 24), days 60 (38–85) 67 (47–82) 42 (35–85) 0.590
MV post-ECMO, days 20 (12–29) 27 (14–31) 14.5 (10.3–23) 0.157
In survivors (n = 24), days 18 (12–29) 27 (14–31) 14 (9.5–21) 0.124
ECMO duration, days 38 (18–56) 36 (26–53) 41 (18–57) 0.705
In survivors (n = 24), days 32 (17–47) 36 (18–45) 27 (14–51) 0.543
ICU length of stay, days 47 (1–83) 61 (11–97) 38 (1–54) 0.298
In survivors, days 65 (46–101) 86 (61–113) 47 (40–89) 0.134
ICU Mortality, n (%) 39 (62) 26 (67) 13 (54) 0.321

MV Mechanical ventilation, VAP Ventilator acquired pneumonia, ICU Intensive care unit